China Approves First Homegrown Covid Pill

Genuine applied for approval in early July to sell the antiviral pill as China’s first marketed homegrown oral Covid-19 treatment.

(Bloomberg) — China approved its first homegrown Covid antiviral as regulators cleared a medicine from Genuine Biotech that was previously used to treat HIV.

The National Medical Products Administration gave the nod to Azvudine from the Henan-based drug company for adults with normal symptoms under an emergency use authorization, according to a statement issued Monday by the agency.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS